Motivation : Molecular signatures for diagnosis or prognosis estimated from large-scale gene expression data often lack robustness and stability, rendering their biological interpretation challenging. Increasing the signature's interpretability and stability across perturbations of a given dataset and, if possible, across datasets, is urgently needed to ease the discovery of important biological processes and, eventually, new drug targets. Results : We propose a new method to construct signatures with increased stability and easier interpretability. The method uses a gene network as side interpretation and enforces a large connectivity among the genes in the signature, leading to signatures typically made of genes clustered in a few subnetw...
Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughpu...
Background: Various gene-expression signatures for breast cancer are available for the prediction of...
Gene expression signatures of toxicity and clinical response benefit both safety assessment and clin...
Diagnostic and prognostic biomarkers for cancer based on gene expression profiles are viewed as a ma...
Important developments in biotechnologies have moved the paradigm of gene expression analysis from a...
The main objective of this study is to develop a novel network-based methodology to identify prognos...
De considérables développements dans le domaine des biotechnologies ont modifié notre approche de l'...
Abstract Background Our goal was to examine how various aspects of a gene signature influence the su...
Background: Highly parallel analysis of gene expression has recently been used to identify gene sets...
Cancer prognosis can be regarded as estimating the risk of future outcomes from multiple variables. ...
Background The development of expression-based gene signatures for predicting prognosis or class mem...
International audienceMotivation: Biomarker discovery from high-dimensional data is a crucial proble...
Scientific advances are raising expectations that patient-tailored treatment will soon be available....
BACKGROUND: Highly parallel analysis of gene expression has recently been used to identify gene sets...
Background: Gene expression connectivity mapping has gained much popularity recently with a number o...
Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughpu...
Background: Various gene-expression signatures for breast cancer are available for the prediction of...
Gene expression signatures of toxicity and clinical response benefit both safety assessment and clin...
Diagnostic and prognostic biomarkers for cancer based on gene expression profiles are viewed as a ma...
Important developments in biotechnologies have moved the paradigm of gene expression analysis from a...
The main objective of this study is to develop a novel network-based methodology to identify prognos...
De considérables développements dans le domaine des biotechnologies ont modifié notre approche de l'...
Abstract Background Our goal was to examine how various aspects of a gene signature influence the su...
Background: Highly parallel analysis of gene expression has recently been used to identify gene sets...
Cancer prognosis can be regarded as estimating the risk of future outcomes from multiple variables. ...
Background The development of expression-based gene signatures for predicting prognosis or class mem...
International audienceMotivation: Biomarker discovery from high-dimensional data is a crucial proble...
Scientific advances are raising expectations that patient-tailored treatment will soon be available....
BACKGROUND: Highly parallel analysis of gene expression has recently been used to identify gene sets...
Background: Gene expression connectivity mapping has gained much popularity recently with a number o...
Identifying relevant signatures for clinical patient outcome is a fundamental task in high-throughpu...
Background: Various gene-expression signatures for breast cancer are available for the prediction of...
Gene expression signatures of toxicity and clinical response benefit both safety assessment and clin...